Point72 Europe (London) LLP Uni Qure N.V. Transaction History
Point72 Europe (London) LLP
- $1.97 Billion
- Q3 2025
A detailed history of Point72 Europe (London) LLP transactions in Uni Qure N.V. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 1,552 shares of QURE stock, worth $46,373. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,552Holding current value
$46,373% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding QURE
# of Institutions
267Shares Held
51.1MCall Options Held
3.92MPut Options Held
4M-
Avoro Capital Advisors LLC New York, NY4.44MShares$133 Million3.54% of portfolio
-
Rtw Investments, LP New York, NY4.42MShares$132 Million3.45% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$119 Million17.49% of portfolio
-
Abrdn PLC2.94MShares$87.8 Million0.28% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$59.4 Million0.03% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $1.4B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...